New flu shot for toddlers shows promise in major trial

NCT ID NCT05645900

Summary

This study tested a new four-strain flu vaccine in very young children to see if it is safe and if it triggers a strong immune response. It involved 2,772 healthy children aged 6 to 35 months, who received two doses of either the new vaccine or a control vaccine. Researchers closely monitored the children for any side effects and measured their antibody levels for six months after vaccination.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLUENZA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Ab&b Biotechnology Co., Ltd.JS

    Taizhou, Jiangsu, 225300, China

Conditions

Explore the condition pages connected to this study.